Organigram Global (STU:0OG) Research & Development: €6.3 Mil (TTM As of Mar. 2026)


STU:0OG Organigram Global Inc STU:0OG
60 GF Score
Price €0.82
GF Value €1.46
Valuation Possible Value Trap
! 1 Warning Sign
View Full Analysis

What is Organigram Global Research & Development?

Organigram Global STU:0OG -0.85% 60 Research & Development is €6.3 Mil as of Mar. 2026. GuruFocus rates STU:0OG with a GF Score™ of 60/100 and a GF Value™ of €1.46 (Possible Value Trap). The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Organigram Global's Research & Development for the three months ended in Mar. 2026 was €1.3 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €6.3 Mil.

Organigram Global  (STU:0OG) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Organigram Global Research & Development Related Terms

Organigram Global Research & Development Historical Data

* Premium members only.

The historical data trend for Organigram Global's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Organigram Global Research & Development Chart

Organigram Global Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Sep24 Sep25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.81 2.46 4.56 7.45 6.74

Organigram Global Quarterly Data
Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.72 1.75 1.94 1.29 1.28
STU:0OG
60GF Score
Organigram Global Inc STU:0OG
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Organigram Global Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €6.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €6.3 Mil mean?
Organigram Global (STU:0OG) has a Research & Development of €6.3 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Organigram Global and its competitors.
Is Organigram Global's Research & Development too high?
Organigram Global's current Research & Development is €6.3 Mil. Overall, Organigram Global has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Organigram Global's Research & Development compare to ZTS?
Organigram Global's Research & Development of €6.3 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Organigram Global and its competitors. Organigram Global's current Research & Development is €6.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Organigram Global stock overvalued right now?
Based on GuruFocus' analysis, Organigram Global (STU:0OG) is currently considered Possible Value Trap. The stock's GF Value™ is €1.46, compared to a current price of €0.82 — trading 44.1% below its estimated fair value. The current Research & Development is €6.3 Mil. Organigram Global's overall GF Score™ is 60/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Organigram Global (STU:0OG), the current Research & Development is €6.3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Organigram Global (STU:0OG) Overvalued in 2026?

Based on GuruFocus' analysis, Organigram Global stock appears to be undervalued. The current stock price of €0.82 is trading 44.1% below its estimated GF Value™ of €1.46. GuruFocus considers Organigram Global to be Possible Value Trap.

Key valuation signals for STU:0OG:

  • Research & Development: €6.3 Mil
  • GF Value™: €1.46 vs. price of €0.82 (44.1% below fair value)
  • GF Score™: 60/100 with 1 warning sign

No single metric tells the full story. See the STU:0OG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Organigram Global Business Description

Other Exchanges OGI:USAOGI:Canada
Address 145 King Street West, Suite 1400, Toronto, ON, CAN, M5H 1J8
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
60GF Score

Get the complete analysis for STU:0OG

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.82
Price
€1.46
GF Value